# Klinische Forschung & kliniknahe Grundlagenforschung

**Funder:** Deutsche Krebshilfe
**Consortium:** No
**Application:** Single stage via online portal (signed printed copy also required)
**Frequency:** Continuous
**Eligible countries:** DE
**Official call:** https://www.krebshilfe.de/forschen/foerderung/foerderprogramme/klinische-forschung-kliniknahe-grundlagenforschung/
**Last verified:** 26 July 2026

## Eligibility & scope

Funds time-limited innovative oncology research projects in clinical or clinically-oriented basic cancer research. Open to early-career and established researchers with at least a doctorate. Proposals must be submitted in English. Commercial-interest projects excluded; scientific consortia (>2 groups, independent sub-projects) not eligible under this scheme.

## Summary

Deutsche Krebshilfe's Klinische Forschung & kliniknahe Grundlagenforschung programme funds innovative, time-limited oncology research in clinical and clinically-oriented basic science, open to researchers with a doctorate at German non-commercial institutions. The call accepts applications continuously with no fixed deadline, making it suitable for researchers ready to move quickly. Both early-career and established investigators are eligible, provided proposals are submitted in English.

## Who should apply

- Researchers with a doctorate in oncology or related cancer research fields
- Applicants based at non-commercial German institutions (universities, hospitals, research centres)
- Investigators pursuing clinical cancer research or clinically-oriented fundamental oncology work
- Early-career and established researchers (no career-stage ceiling)
- Projects with a clearly defined, time-limited scope and publishable results

## Key dates

- Rolling deadline, applications accepted at any time
- Single-stage evaluation via online portal with printed copy submission
- Continuous call with no seasonal windows

## Tips for applicants

- Emphasise clinical relevance or translational pathway explicitly; this funder prioritises clinically-oriented work over purely fundamental oncology.
- Submit proposals in English even if your institution is German; language clarity strengthens international review panels.
- Avoid multi-group consortia structures; this call excludes scientific consortia with more than two independent working groups.

## Frequently asked questions

### Who can apply to the Deutsche Krebshilfe Klinische Forschung programme?

Researchers with a doctorate working in clinical cancer research or clinically-oriented basic oncology, based at non-commercial German institutions.

### Are there fixed deadlines for Deutsche Krebshilfe Klinische Forschung?

No; the call operates on a rolling deadline, so applications can be submitted at any time.

### Can international research teams apply to this Deutsche Krebshilfe call?

The applicant and host institution must be based in Germany; proposals should be submitted in English for international review.

### Are large consortia eligible for this funding?

No; scientific consortia with more than two independent working groups are excluded from this programme.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/deutsche-krebshilfe-klinische-forschung-kliniknahe-grundlagenforschung-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).